Ideaya Biosciences Inc (IDYA) - News Archive

Breaking Barriers: IDEAYA Biosciences Unveils Promising BsADC Candidate in Challenging Market Landscape In an exciting development for the pharmaceutical industry, IDEAYA Biosciences, Inc. (Nasdaq: IDYA) has announced p...

In a significant advancement within the biotechnology sector, Biocytogen Pharmaceuticals (Beijing) Co. Ltd. has announced that IDEAYA Biosciences, Inc. has exercised its option for an exclusive worldwide license regardi...

IDEAYA Biosciences Advances Cancer Therapeutics with B7H3/PTK7-ADCIDEAYA Biosciences, Inc. (Nasdaq: IDYA) is making significant strides in the field of cancer therapeutics with its latest development of the B7H3/PTK7 an...

In a significant move that promises to advance the field of targeted cancer therapies, Biocytogen Pharmaceuticals (Beijing) Co., Ltd., recently announced an option and license agreement with IDEAYA Biosciences, Inc. Thi...

IDEAYA Biosciences Appoints Daniel A. Simon as Chief Business Officer to Lead Corporate Strategy and Business DevelopmentIDEAYA Biosciences, a precision medicine company specializing in oncology, has recently announced...